These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18057308)

  • 21. Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury.
    Rosenberger C; Rosen S; Heyman SN
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):980-8. PubMed ID: 17002677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
    Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
    Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
    Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Review of the radiocontrast nephropathy risk profiles and risk stratification].
    Toprak O; Cirit M; Bayata S; Yeşil M
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):331-5. PubMed ID: 15590363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dye-induced nephropathy.
    Heyman SN; Rosen S
    Semin Nephrol; 2003 Sep; 23(5):477-85. PubMed ID: 13680537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetylcysteine ameliorates renal microcirculation: studies in rats.
    Heyman SN; Goldfarb M; Shina A; Karmeli F; Rosen S
    Kidney Int; 2003 Feb; 63(2):634-41. PubMed ID: 12631128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
    Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
    Asif A; Epstein DL; Epstein M
    J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiocontrast induced nephropathy.
    Lindholt JS
    Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):296-304. PubMed ID: 12651166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiocontrast-associated renal dysfunction: incidence and risk factors.
    Lautin EM; Freeman NJ; Schoenfeld AH; Bakal CW; Haramati N; Friedman AC; Lautin JL; Braha S; Kadish EG; Sprayregen S
    AJR Am J Roentgenol; 1991 Jul; 157(1):49-58. PubMed ID: 2048539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contrast-induced nephropathy].
    Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
    Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parstatin prevents renal injury following ischemia/reperfusion and radiocontrast administration.
    Diamantopoulos A; Kyriazis I; Geronatsiou K; Papadaki H; Loudos G; Kagadis GC; Katsanos K; Liatsikos E; Karnabatidis D; Siamblis D; Tsopanoglou NE
    Am J Nephrol; 2012; 36(3):278-86. PubMed ID: 22965158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute kidney injury in the diabetic rat: studies in the isolated perfused and intact kidney.
    Rosenberger C; Khamaisi M; Goldfarb M; Shina A; Shilo V; Zilbertrest F; Rosen S; Heyman SN
    Am J Nephrol; 2008; 28(5):831-9. PubMed ID: 18535369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute renal failure with selective medullary injury in the rat.
    Heyman SN; Brezis M; Reubinoff CA; Greenfeld Z; Lechene C; Epstein FH; Rosen S
    J Clin Invest; 1988 Aug; 82(2):401-12. PubMed ID: 3403711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incomplete Recovery from the Radiocontrast-Induced Dysregulated Cell Cycle, Adhesion, and Fibrogenesis in Renal Tubular Cells after Radiocontrast (Iohexol) Removal.
    Chen HY; Wu YH; Wei CY; Liao ZY; Wu HT; Chen YC; Pang JS
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
    An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial safety of radiological contrast media: why being concerned.
    Scoditti E; Massaro M; Montinari MR
    Vascul Pharmacol; 2013 Jan; 58(1-2):48-53. PubMed ID: 23085042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of N-acetylcysteine on renal hemodynamics in contrast media-induced nephropathy.
    Krzossok S; Braun C; Weiss E; Hoeger S; Schnuelle P; Benck U; Birck R; Krämer BK; Göttmann U
    Kidney Blood Press Res; 2011; 34(2):125-34. PubMed ID: 21335974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease.
    Heyman SN; Khamaisi M; Rosen S; Rosenberger C
    Am J Nephrol; 2008; 28(6):998-1006. PubMed ID: 18635927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography.
    Traub SJ; Kellum JA; Tang A; Cataldo L; Kancharla A; Shapiro NI
    Acad Emerg Med; 2013 Jan; 20(1):40-5. PubMed ID: 23570477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.